Metastatic Renal Cell Carcinoma Completed Phase 1 Trials for Sunitinib (DB01268)

Also known as: Metastatic Renal cell carcinoma

IndicationStatusPhase
DBCOND0030098 (Metastatic Renal Cell Carcinoma)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00421512A Phase I Study of Bevacizumab and Sunitinib in Metastatic Renal Cell Carcinoma PatientsTreatment